Silvant Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,009
| Closed | -$1.79M | – | 318 |
|
|
2025
Q1 | $1.79M | Hold |
28,009
| – | – | 0.08% | 129 |
|
|
2024
Q4 | $3.41M | Hold |
28,009
| – | – | 0.14% | 92 |
|
|
2024
Q3 | $3.5M | Buy |
28,009
+2,950
| +12% | +$368K | 0.15% | 90 |
|
|
2024
Q2 | $3.96M | Buy |
25,059
+9,221
| +58% | +$1.46M | 0.18% | 77 |
|
|
2024
Q1 | $2.05M | Hold |
15,838
| – | – | 0.1% | 118 |
|
|
2023
Q4 | $1.53M | Hold |
15,838
| – | – | 0.08% | 125 |
|
|
2023
Q3 | $1.92M | Hold |
15,838
| – | – | 0.12% | 111 |
|
|
2023
Q2 | $1.81M | Sell |
15,838
-8,096
| -34% | -$927K | 0.1% | 115 |
|
|
2023
Q1 | $3.3M | Buy |
23,934
+5,616
| +31% | +$774K | 0.21% | 85 |
|
|
2022
Q4 | $2.37M | Buy |
18,318
+14,290
| +355% | +$1.85M | 0.17% | 100 |
|
|
2022
Q3 | $445K | Hold |
4,028
| – | – | 0.03% | 151 |
|
|
2022
Q2 | $302K | Hold |
4,028
| – | – | 0.07% | 125 |
|
|
2022
Q1 | $315K | Hold |
4,028
| – | – | 0.06% | 140 |
|
|
2021
Q4 | $363K | Sell |
4,028
-259
| -6% | -$23.3K | 0.06% | 134 |
|
|
2021
Q3 | $396K | Hold |
4,287
| – | – | 0.07% | 133 |
|
|
2021
Q2 | $333K | Hold |
4,287
| – | – | 0.05% | 151 |
|
|
2021
Q1 | $320K | Sell |
4,287
-106
| -2% | -$7.91K | 0.05% | 153 |
|
|
2020
Q4 | $749K | Hold |
4,393
| – | – | 0.13% | 106 |
|
|
2020
Q3 | $617K | Hold |
4,393
| – | – | 0.12% | 105 |
|
|
2020
Q2 | $704K | Hold |
4,393
| – | – | 0.13% | 101 |
|
|
2020
Q1 | $430K | Hold |
4,393
| – | – | 0.09% | 111 |
|
|
2019
Q4 | $567K | Hold |
4,393
| – | – | 0.1% | 105 |
|
|
2019
Q3 | $331K | Hold |
4,393
| – | – | 0.07% | 135 |
|
|
2019
Q2 | $668K | Hold |
4,393
| – | – | 0.12% | 104 |
|
|
2019
Q1 | $524K | Hold |
4,393
| – | – | 0.09% | 110 |
|
|
2018
Q4 | $479K | Hold |
4,393
| – | – | 0.1% | 112 |
|
|
2018
Q3 | $710K | Hold |
4,393
| – | – | 0.09% | 107 |
|
|
2018
Q2 | $581K | Sell |
4,393
-807
| -16% | -$107K | 0.07% | 109 |
|
|
2018
Q1 | $385K | Buy |
+5,200
| New | +$385K | 0.05% | 138 |
|